Insilico Medicine 20 avr. 2026 Insilico Medicine Advances AI-Driven Target Discovery with Validated TargetPro–TargetBench Framework - Insilico Medicine
Insilico Medicine 20 avr. 2026 Insilico Medicine Showcases AI Drug Discovery Platform at AACR 2026 - TipRanks
Insilico Medicine 29 mars 2026 Insilico Medicine Announces 2025 Annual Results, Redefining Value Delivery in AI-Powered Drug Discovery - Insilico Medicine
Endpoints News 27 janv. 2026 Insilico’s latest deal is a $120M cardiometabolic drug discovery pact with Qilu Pharma
FierceBiotech 27 janv. 2026 Qilu programs path into cardiometabolic disease with $120M, AI-enabled Insilico alliance
Endpoints News 21 janv. 2026 Fosun-funded Hygtia Therapeutics licenses Insilico’s NLRP3 inhibitor for Parkinson’s